...
首页> 外文期刊>International Journal of Biomaterials >The Blood Compatibilities of Blood Purification Membranes and Other Materials Developed in Japan
【24h】

The Blood Compatibilities of Blood Purification Membranes and Other Materials Developed in Japan

机译:日本开发的血液净化膜和其他材料的血液相容性

获取原文

摘要

The biocompatibilities in blood purification therapy are defined as “a concept to stipulate safety of blood purification therapy by an index based on interaction in the body arising from blood purification therapy itself.” The biocompatibilities are associated with not only materials to be used but also many factors such as sterilization method and eluted substance. It is often evaluated based on impacts on cellular pathways and on humoral pathways. Since the biocompatibilities of blood purification therapy in particular hemodialysis are not just a prognostic factor for dialysis patients but a contributory factor for long-term complications, it should be considered with adequate attention. It is important that blood purification therapy should be performed by consistently evaluating not only risks associated with these biocompatibilities but also the other advantages obtained from treatments. In this paper, the biocompatibilities of membrane and adsorption material based on Japanese original which are used for blood purification therapy are described.
机译:血液净化疗法的生物相容性被定义为“通过基于血液净化疗法本身引起的体内相互作用的指标来规定血液净化疗法的安全性的概念。”生物相容性不仅与要使用的材料有关,而且与许多因素有关,例如灭菌方法和洗脱物质。通常根据对细胞途径和体液途径的影响进行评估。由于血液净化治疗的生物相容性,尤其是血液透析,不仅是透析患者的预后因素,而且还是长期并发症的因素,因此应给予足够的重视。重要的是,血液净化治疗应不仅通过持续评估与这些生物相容性相关的风险,而且还应从治疗中获得的其他优势来进行评估。本文描述了用于血液净化治疗的膜和基于日本原版的吸附材料的生物相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号